BioSpace News Archive

Antibe Therapeutics Inc. is pleased to announce the completion of the pharmacokinetic/pharmacodynamic (“PK/PD”) study of otenaproxesul’s faster-absorbing formulation for acute pain.

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2023.

Aldeyra Therapeutics, Inc. today announced that it has entered into an exclusive option agreement with AbbVie Inc. (AbbVie).

Sensei Biotherapeutics, Inc. today announced the appointment of Stephanie Krebs, MS, MBA, as Chief Business Officer.

HCW Biologics Inc. will have a human data readout at the 38th Annual Meeting of the Society for Immunotherapy of Cancer from an ongoing Phase 1 clinical trial to evaluate HCW9218 in patients with chemo-refractory/chemo-resistant solid tumors, conducted by the Masonic Cancer Center, University of Minnesota.

Daewoong Pharmaceutical is pleased to announce its financial results for the third quarter of 2023.

Leiden, The Netherlands, November 1, 2023: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of November:.

argenx SE announced 20 presentations of clinical trial and real-world data from studies of VYVGART® and VYVGART Hytrulo® in neuromuscular autoimmune disease.

ViroCell Biologics announces that the Company is now able to manufacture and globally export viral vectors from Great Ormond Street Hospital’s state-of-the-art manufacturing facility, the Zayed Centre for Research, for use in clinical trials.

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that company management will participate in the following conferences and invited investors to participate by webcast.